News

"A lot of them signed it. I thought it looked really cool, and I think they are going to look sick with it on them," said ...
From new cancer therapies to innovative military health care and technology, Harvard's cutting-edge projects are in jeopardy ...
Petersen’s Bloomfield Hills home with his wife, Jo Anne Petersen, is open to the public April 25-27 for one of the most ...
Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...
Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...
Time is running out for a chance to win the Coachella Valley St. Jude Dream Home giveaway. Call the number on your screen to ...
Both those receiving either expected or less-than-expected starting dosages of ruxolitinib for myelofibrosis treatment ...
Agenus Inc. , a clinical-stage immuno-oncology company, today announced updated data from the hepatocellular carcinoma (HCC) cohort of its ongoing Phase 1 study evaluating botensilimab (BOT) in ...
Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it will present preclinical data of FL-501 in a poster presentation ...
Nimbus Therapeutics announced the launch of a first-in-human clinical trial for NDI-219216, its investigational Werner ...
During Friday's final spring practice, SMU football players will proudly wear a new helmet designed by an inspiring 11-year-old cancer survivor with big dreams for his future. "I want to be a lot of ...